Testing the effects of Δ9-THC and D-cycloserine on extinction of conditioned fear in humans

Journal of Psychopharmacology

Volumn 26, Issue 4, 2012, Pages 471-478

  Klumpers, Floris ^a,b   Denys, Damiaan ^c   Kenemans, J Leon ^a,b   Grillon, Christian ^d   Van Der Aart, Jasper ^a   Baas, Johanna M P ^a,b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

9 THC; d cycloserine; extinction; fear conditioning; fear potentiated startle; human

Indexed keywords

CYCLOSERINE; DRONABINOL; PLACEBO;

ADULT; ARTICLE; CONDITIONING; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEAR; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PARALLEL DESIGN; PRIORITY JOURNAL; REINFORCEMENT; SINGLE DRUG DOSE; SKIN CONDUCTANCE; STARTLE REFLEX;

ADOLESCENT; ADULT; CONDITIONING (PSYCHOLOGY); CYCLOSERINE; DOUBLE-BLIND METHOD; EXTINCTION, PSYCHOLOGICAL; FEAR; FEMALE; HUMANS; MALE; STARTLE REACTION; TETRAHYDROCANNABINOL;

EID: 84860152546     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881111431624     Document Type: Article

References (57)

1. Alvarez RP, Johnson L, Grillon C. Contextual-specificity of short-delay extinction in humans: renewal of fear-potentiated startle in a virtual environment. Learn Mem. 2007 ; 14: 247-253
2. Bitencourt RM, Pamplona FA, Takahashi RN. Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned rats. Eur Neuropsychopharmacol. 2008 ; 18: 849-859
3. Bouton ME, Vurbic D, Woods AM. D-cycloserine facilitates context-specific fear extinction learning. Neurobiol Learn Mem. 2008 ; 90: 504-510
4. Chhatwal JP, Davis M, Maguschak KA, et al. Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear. Neuropsychopharmacology. 2005 ; 30: 516-524
5. Curran HV, Brignell C, Fletcher S, et al. Cognitive and subjective dose-response effects of acute oral Delta 9-tetrahydrocannabinol (THC) in infrequent cannabis users. Psychopharmacology (Berl). 2002 ; 164: 61-70
6. Davis M. Role of NMDA receptors and MAP kinase in the amygdala in extinction of fear: clinical implications for exposure therapy. Eur J Neurosci. 2002 ; 16: 395-398
7. Davis M, Falls WA, Campeau S, et al. Fear-potentiated startle: a neural and pharmacological analysis. Behav Brain Res. 1993 ; 58: 175-198
8. Davis M, Ressler K, Rothbaum BO, et al. Effects of D-cycloserine on extinction: translation from preclinical to clinical work. Biol Psychiatry. 2006 ; 60: 369-375
9. Falls WA, Miserendino MJ, Davis M. Extinction of fear-potentiated startle: blockade by infusion of an NMDA antagonist into the amygdala. J Neurosci. 1992 ; 12: 854-863
10. Flood JF, Morley JE, Lanthorn TH. Effect on memory processing by D-cycloserine, an agonist of the NMDA/glycine receptor. Eur J Pharmacol. 1992 ; 221: 249-254
11. Graham SJ, Scaife JC, Langley RW, et al. Effects of lorazepam on fear-potentiated startle responses in man. J Psychopharmacol. 2005 ; 19: 249-258
12. Grillon C. D-cycloserine facilitation of fear extinction and exposure-based therapy might rely on lower-level, automatic mechanisms. Biol Psychiatry. 2009 ; 66: 636-641
13. Grillon C, Baas JMP. Comments on the use of the startle reflex in psychopharmacological challenges: impact of baseline startle on measurement of fear-potentiated startle. Psychopharmacol. 2002 ; 164: 236-238
14. Grillon C, Baas JMP. A review of the modulation of the startle reflex by affective states and its application in psychiatry. Clin Neurophysiol. 2003 ; 114: 1557-1579
15. Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet. 2003 ; 42: 327-360
16. Guastella AJ, Dadds MR, Lovibond PF, et al. A randomized controlled trial of the effect of D-cycloserine on exposure therapy for spider fear. J Psychiatr Res. 2007a ; 41: 466-471
17. Guastella AJ, Lovibond PF, Dadds MR, et al. A randomized controlled trial of the effect of D-cycloserine on extinction and fear conditioning in humans. Behav Res Ther. 2007b ; 45: 663-672
18. Guastella AJ, Richardson R, Lovibond PF, et al. A randomized controlled trial of D-cycloserine enhancement of exposure therapy for social anxiety disorder. Biol Psychiatry. 2008 ; 63: 544-549
19. Hamm AO, Vaitl D. Affective learning: awareness and aversion. Psychophysiology. 1996 ; 33: 698-710
20. Hofmann SG, Meuret AE, Smits JA, et al. Augmentation of exposure therapy with D-cycloserine for social anxiety disorder. Arch Gen Psychiatry. 2006 ; 63: 298-304
21. Hoyer D, Boddeke HW. Partial agonists, full agonists, antagonists: dilemmas of definition. Trends Pharmacol Sci. 1993 ; 14: 270-275
22. Kamprath K, Marsicano G, Tang J, et al. Cannabinoid CB1 receptor mediates fear extinction via habituation-like processes. J Neurosci. 2006 ; 26: 6677-6686
23. Kindt M, Soeter M, Vervliet B. Beyond extinction: erasing human fear responses and preventing the return of fear. Nat Neurosci. 2009 ; 12: 256-258
24. Kushner MG, Kim SW, Donahue C, et al. D-cycloserine augmented exposure therapy for obsessive-compulsive disorder. Biol Psychiatry. 2007 ; 62: 835-838
25. Laaris N, Good CH, Lupica CR. Delta9-tetrahydrocannabinol is a full agonist at CB1 receptors on GABA neuron axon terminals in the hippocampus. Neuropharmacology. 2010 ; 59: 121-127
26. Lang PJ, Bradley MM, Cuthbert BN. Emotion, attention, and the startle reflex. Psychol Rev. 1990 ; 97: 377-395
27. Lee JL, Milton AL, Everitt BJ. Reconsolidation and extinction of conditioned fear: inhibition and potentiation. J Neurosci. 2006 ; 26: 10051-10056
28. Marsicano G, Wotjak CT, Azad SC, et al. The endogenous cannabinoid system controls extinction of aversive memories. Nature. 2002 ; 418: 530-534
29. McDonald J, Schleifer L, Richards JB, et al. Effects of THC on behavioral measures of impulsivity in humans. Neuropsychopharmacology. 2003 ; 28: 1356-1365
30. Mineka S, Oehlberg K. The relevance of recent developments in classical conditioning to understanding the etiology and maintenance of anxiety disorders. Acta Psychol (Amst). 2008 ; 127: 567-580
31. Monahan JB, Handelmann GE, Hood WF, et al. D-cycloserine, a positive modulator of the N-methyl-D-aspartate receptor, enhances performance of learning tasks in rats. Pharmacol Biochem Behav. 1989 ; 34: 649-653
32. Moreira FA, Lutz B. The endocannabinoid system: emotion, learning and addiction. Addict Biol. 2008 ; 13: 196-212
33. Myers KM, Davis M. Mechanisms of fear extinction. Mol Psychiatry. 2007 ; 12: 120-150
34. Myers KM, Carlezon WA, Davis M. Glutamate receptors in extinction and extinction-based therapies for psychiatric illness. Neuropsychopharmacology. 2011 ; 36: 274-293
35. Norberg MM, Krystal JH, Tolin DF. A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy. Biol Psychiatry. 2008 ; 63: 1118-1126
36. Norrholm SD, Jovanovic T, Vervliet B, et al. Conditioned fear extinction and reinstatement in a human fear-potentiated startle paradigm. Learn Mem. 2006 ; 13: 681-685
37. Pamplona FA, Prediger RD, Pandolfo P, et al. The cannabinoid receptor agonist WIN 55, 212-2 facilitates the extinction of contextual fear memory and spatial memory in rats. Psychopharmacology (Berl). 2006 ; 188: 641-649
38. Phan KL, Angstadt M, Golden J, et al. Cannabinoid modulation of amygdala reactivity to social signals of threat in humans. J Neurosci. 2008 ; 28: 2313-2319
39. Plendl W, Wotjak CT. Dissociation of within- and between-session extinction of conditioned fear. J Neurosci. 2010 ; 30: 4990-4998
40. Ressler KJ, Rothbaum BO, Tannenbaum L, et al. Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear. Arch Gen Psychiatry. 2004 ; 61: 1136-1144
41. Spielberger CD Manual for the State-Trait Anxiety Inventory. Palo Alto: Consulting Psychologist Press ; 1972 :
42. Steele RJ, Dermon CR, Stewart MG. D-cycloserine causes transient enhancement of memory for a weak aversive stimulus in day-old chicks (Gallus domesticus). Neurobiol Learn Mem. 1996 ; 66: 236-240
43. Storch EA, Merlo LJ, Bengtson M, et al. D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder. Int Clin Psychopharmacol. 2007 ; 22: 230-237
44. Storch EA, Murphy TK, Goodman WK, et al. A preliminary study of D-cycloserine augmentation of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder. Biol Psychiatry. 2010 ; 68: 1073-1076
45. Thompson LT, Disterhoft JF. Age- and dose-dependent facilitation of associative eyeblink conditioning by D-cycloserine in rabbits. Behav Neurosci. 1997 ; 111: 1303-1312
46. van Berckel BN, Lipsch C, Gispen-de Wied C, et al. The partial NMDA agonist D-cycloserine stimulates LH secretion in healthy volunteers. Psychopharmacology (Berl). 1998 ; 138: 190-197
47. van Berckel BN, Lipsch C, Timp S, et al. Behavioral and neuroendocrine effects of the partial NMDA agonist D-cycloserine in healthy subjects. Neuropsychopharmacology. 1997 ; 16: 317-324
48. Van Vliet I. M., De Beurs E.. The MINI-International Neuropsychiatric Interview. A brief structured diagnostic psychiatric interview for DSM-IV en ICD-10 psychiatric disorders. Tijdschr Psychiatr. 2007 ; 49: 393-397
49. Vansteenwegen D, Crombez G, Baeyens F, et al. Extinction in fear conditioning: effects on startle modulation and evaluative self-reports. Psychophysiology. 1998 ; 35: 729-736
50. Vervliet B. Learning and memory in conditioned fear extinction: effects of D-cycloserine. Acta Psychol (Amst). 2008 ; 127: 601-613
51. Viveros MP, Marco EM, File SE. Endocannabinoid system and stress and anxiety responses. Pharmacol Biochem Behav. 2005 ; 81: 331-342
52. Wachtel SR, ElSohly MA, Ross SA, et al. Comparison of the subjective effects of Delta(9)-tetrahydrocannabinol and marijuana in humans. Psychopharmacology (Berl). 2002 ; 161: 331-339
53. Walker DL, Ressler KJ, Lu KT, et al. Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats. J Neurosci. 2002 ; 22: 2343-2351
54. Weber M, Hart J, Richardson R. Effects of D-cycloserine on extinction of learned fear to an olfactory cue. Neurobiol Learn Mem. 2007 ; 87: 476-482
55. Weike AI, Hamm AO, Schupp HT, et al. Fear conditioning following unilateral temporal lobectomy: dissociation of conditioned startle potentiation and autonomic learning. J Neurosci. 2005 ; 25: 11117-11124
56. Wilhelm S, Buhlmann U, Tolin DF, et al Am J Psychiatry. 335-341; quiz ; 2008: 409.
57. Zuurman L, Ippel AE, Moin E, et al. Biomarkers for the effects of cannabis and THC in healthy volunteers. Br J Clin Pharmacol. 2009 ; 67: 5-21